Tetrazole Anticancer and Antibodies

Authors

  • Azher Majeed Abd Al-Zhara Tawi University of Karbala College of science Chemistry Department Author
  • Haneen Ahmed jassim Mohammad University of Karbala College of science Chemistry Department Author
  • Maha Naama dakhil debis University of Karbala College of science Chemistry Department Author
  • Ayat Arif Abdul Abbas Sahib University of Karbala College of science Chemistry Department Author
  • Zainab Mohammed Abod Mahdi University of Karbala College of science Chemistry Department Author

Abstract

Tetrazole derivatives are a prime class of heterocycles, very important to medicinal chemistry and drug design due to not only their bioisosterism to carboxylic acid and amide moieties but also to their metabolic stability and other beneficial physicochemical properties. Although more than 20 FDA-approved drugs contain 1H- or 2H-tetrazole substituents, their exact binding mode, structural biology, 3D conformations, and in general their chemical behavior is not fully understood. Importantly, multicomponent reaction (MCR) chemistry offers convergent access to multiple tetrazole scaffolds providing the three important elements of novelty, diversity, and complexity, yet MCR pathways to tetrazoles are far from completely explored. Here, we review the use of multicomponent reactions for the preparation of substituted tetrazole derivatives. We highlight specific applications and general trends holding therein and discuss synthetic approaches and their value by analyzing scope and limitations, and also enlighten their receptor binding mode. Finally.

Published

2024-08-10

How to Cite

Tetrazole Anticancer and Antibodies. (2024). Innovative: International Multidisciplinary Journal of Applied Technology (2995-486X), 2(7), 91-96. https://multijournals.org/index.php/innovative/article/view/1945